By
Adrianne Appel2023-03-30T21:29:00
A former chief compliance officer who pleaded guilty to aiding widescale opioid distribution at a wholesale pharmacy where he worked received no jail time after testifying against his former chief executive officer.
William Pietruszewski, the former CCO of Rochester Drug Co-operative (RDC), was spared jail time by Judge George Daniels of the Southern District of New York in a ruling Wednesday. Pietruszewski’s testimony aided the Department of Justice’s (DOJ) case against former RDC CEO Laurence Doud III, who was sentenced to two years and three months in prison earlier this month.
The Pietruszewski ruling was confirmed by his legal representatives at Porzio Bromberg & Newman in a press release.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2024-09-13T18:06:00Z By Adrianne Appel
Former executives of Medly, an online pharmacy that is now shuttered, have been charged by the Securities and Exchange Commission with defrauding investors.
2023-03-14T20:53:00Z By Adrianne Appel
The Department of Justice announced its intervention in a lawsuit alleging retail pharmacy chain Rite Aid filled hundreds of thousands of prescriptions for medically unnecessary oxycodone and other opioids in violation of multiple federal laws.
2022-11-15T18:29:00Z By Kyle Brasseur
Walmart announced it agreed to a $3.1 billion nationwide settlement designed to resolve all the potential state lawsuits it faces for its alleged role in fueling the opioid epidemic.
2026-02-05T00:55:00Z By Ruth Prickett
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
2026-02-03T23:22:00Z By Neil Hodge
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
2026-02-03T22:57:00Z By Adrianne Appel
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
Site powered by Webvision Cloud